info@strategicmarketresearch.com
26, Broadway, Suite 934, New York , 10004
Indian Flag  IN: +91-826-083-6500
Home » healthcare

Healthcare

Photomedicine Market by Technology (Laser Therapy, LED Therapy, Photodynamic Therapy, Other Light Modalities); By Application (Cancer Treatment, Wound Healing, Dermatology, Pain Management, Other Applications); By End-User (Hospitals, Dermatology Clinics, Aesthetic Centers, Research Institutions, Homecare Settings); By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa); Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Photomedicine Market is expected to grow at a robust compound annual growth rate (CAGR) of 7.5%, valued at approximately USD 4.5 billion ... Read More

Published Date: JAN-2026 | No Of Pages:199 | $ 4485

5-Alpha Reductase Deficiency Market By Diagnostic Type (Genetic Testing, Hormonal Assays, Imaging and Physical Evaluation); By Treatment Type (Hormone Replacement Therapy, Surgical Interventions, Psychological and Gender Support Services); By End User (Pediatric Hospitals and Specialty Clinics, Genetic Testing Laboratories, Research Institutes, Endocrinology and Urology Practices); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global 5-Alpha Reductase Deficiency Market is on track for steady growth, with an estimated value of USD 412.5 million in 2024 and a projected market size of USD 657.8 million by 2030Read More

Published Date: JAN-2026 | No Of Pages:183 | $ 4485

Gynandroblastoma Market By Tumor Subtype (Granulosa-Predominant Mixed Tumors, Sertoli-Leydig-Predominant Mixed Tumors, DICER1-Associated Mixed Tumors, Other Rare Mixed Sex Cord–Stromal Tumors); By Diagnostic Approach (Histopathology and Central Pathology Review, Immunohistochemistry, Molecular Profiling, Germline DICER1 Testing and Genetic Counseling); By Treatment Modality (Surgery, Observation and Long-Term Surveillance, Chemotherapy, Hormonal and Other Recurrent-Disease Therapy); By End User (Tertiary Cancer Centers, Regional Hospitals, Diagnostic and Reference Laboratories, Women’s Health and Fertility Clinics, Genetics Clinics); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Gynandroblastoma Market: Rare-Case Care Pathway, Precision Pathology, and Long-Term Surveillance

The Global Gynandroblastoma Market is valued at USD 154.5 million in 2025 and is projected to reach USD 229.7 million by 2032, expanding at a CAGR of 5.83%, according to S... Read More

Published Date: JUL-2026 | No Of Pages:188 | $ 4485

Brain Abscess Treatment Market By Treatment Type (Antibacterial Drugs, Antifungal Drugs, Antiparasitic Drugs, Neurosurgical Treatment [Needle Aspiration, Surgical Excision]); By Route of Administration (Intravenous, Oral); By Application (Bacterial Brain Abscess, Fungal Brain Abscess, Parasitic Brain Abscess); By End User (Hospitals and Tertiary Care Centers, Neurosurgical Centers, Specialty Clinics, Outpatient Infusion and Home Healthcare Providers); By Geography (North America, Europe, Asia-Pacific, Latin America, Middle East and Africa), Segment Revenue Estimation, Forecast, 2026–2032

Brain Abscess Treatment Market: Emergency Care, Prolonged Therapy, and Neurosurgical Demand Sustain Hospital Revenue

The Global Brain Abscess Treatment Market was valued at USD 2.22 billion in 2025 and is projected to reach USD 3.32 billion by 2032, growing at a CAGR ... Read More

Published Date: JUL-2026 | No Of Pages:199 | $ 4485

Orchiectomy Market By Procedure Type (Simple Orchiectomy, Subcapsular Orchiectomy, Radical Orchiectomy); By Application (Oncology, Gender-Affirming Surgery, Trauma, Others); By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Orchiectomy Market is set to grow steadily between 2024 and 2030. It is valued at USD 476 million in 2024 and projected to reach nearly USD 713 million by 2030, advancing ... Read More

Published Date: JAN-2026 | No Of Pages:159 | $ 4485

Obturation System Market By Product Type (Carrier-Based Systems, Warm Vertical Compaction, Hand-Filling Methods); By Material (Gutta-Percha, Bioceramics); By End User (Dental Clinics, Hospitals, Academic & Research Institutes, Ambulatory Surgical Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Obturation System Market will witness a steady CAGR of 6.8%, valued at USD 0.85 billion in 2024, expected to reach nearly USD 1.3 billion by 2030, accordi... Read More

Published Date: JAN-2026 | No Of Pages:156 | $ 4485

Ipilimumab Market By Product Type (Monotherapy, Combination Therapy); By Application (Melanoma, Lung Cancer, Renal Cell Carcinoma, Hepatocellular Carcinoma, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Ipilimumab Market projected to reach USD 8.3 billion by 2030 from USD 5.2 billion in 2024, registering 8.1% CAGR, supported by melanoma treatment<... Read More

Published Date: JAN-2026 | No Of Pages:171 | $ 4485

Microneedling Market By Device Type (Manual Devices, Automated Devices); By Application (Skin Rejuvenation, Acne Scar Treatment, Hair Regrowth, Stretch Marks); By End User (Dermatology Clinics, Spas and Beauty Salons, Home-use Devices, Medical and Clinical Research Institutions); By Region, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Microneedling Market valued at USD 1.1 billion in 2024 and projected to reach USD 2.1 billion by 2030 at 9.5% CAGR, driven by aesthetic treatments... Read More

Published Date: JAN-2026 | No Of Pages:152 | $ 4485

Thymidylate Synthase Inhibitor Market By Drug Type (5-Fluorouracil, Capecitabine, Pemetrexed, Other Thymidylate Synthase Inhibitors); By Application (Colorectal Cancer, Breast Cancer, Lung Cancer, Other Cancers); By End User (Hospitals, Oncology Clinics, Ambulatory Surgical Centers, Diagnostic Imaging Centers, Research & Academic Institutions); By Region, Segment Revenue Estimation, Forecast, 2024–2030

Thymidylate Synthase Inhibitor Market: Oncology Drug Class Overview and Pipeline Developments (Last Updated on: June-2026)

The Global Thymidylate Synthase Inhibitor Market is expected to experience significant growth between 2024 and 2030, with a p... Read More

Published Date: JAN-2026 | No Of Pages:171 | $ 4485

Spinal Pumps Market By Product Type (Intrathecal Infusion Pumps, Epidural Infusion Pumps); By Application (Chronic Pain Management, Spasticity, Cancer Pain); By End User (Hospitals, Pain Management Clinics, Ambulatory Surgical Centers, Diagnostic Imaging Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Spinal Pumps Market will witness a robust growth trajectory, driven by increasing advancements in medical technology and a growing demand for more targeted pain management solutions. This ... Read More

Published Date: JAN-2026 | No Of Pages:171 | $ 4485

Small Lymphocytic Lymphoma Market By Treatment Type (Targeted Therapies, Monoclonal Antibodies, Chemotherapy and Chemoimmunotherapy, CAR-T and Emerging Immunotherapies, Supportive Care); By Route of Administration (Oral, Intravenous); By Treatment Line (Watchful Waiting and Monitoring, First-Line Treatment, Second-Line Treatment, Third-Line and Later Treatment); By End User/Care Setting (Hospitals, Specialty Clinics, Outpatient Oncology Centres, Diagnostic and Molecular Testing Laboratories); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Small Lymphocytic Lymphoma Market: Long Disease Duration Expands the Commercial Care Window

The Global Small Lymphocytic Lymphoma (SLL) Market is valued at USD 3.70 billion in 2025 and is projected to reach USD 5.63 billion by 2032, expanding at a CAGR of 6.2%, accord... Read More

Published Date: JUL-2026 | No Of Pages:151 | $ 4485

Photostimulable Phosphor Systems Market By Product Type (Fixed Systems, Portable Systems); By Application (General Radiography, Dental, Mammography, Veterinary, Others); By End User (Hospitals, Diagnostic Imaging Centers, Dental Clinics, Veterinary Clinics, Mobile Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Photostimulable Phosphor Systems Market is forecast to register a healthy CAGR of 6.4%, standing at an estimated $3.9 billion in 2024 and projected to reach $5.7 b... Read More

Published Date: JAN-2026 | No Of Pages:170 | $ 4485

Galactosemia Treatment Market By Treatment Type (Dietary Management, Pharmacological Interventions, Enzyme Replacement Therapy, Gene Therapy); By Patient Type (Infants, Adolescents, Adults); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Galactosemia Treatment Market valued at USD 0.42 billion in 2024 and projected to reach USD 0.65 billion by 2030 at 6.5% CAGR, driven by rare dise... Read More

Published Date: JAN-2026 | No Of Pages:163 | $ 4485

Molecular Breast Imaging Market By Product Type (Imaging Systems, Software & Services, Consumables & Accessories); By Detector Technology (Cadmium Zinc Telluride [CZT] Detectors, Sodium Iodide [NaI] Detector Systems); By Application (Supplemental Breast Cancer Screening, Diagnostic Evaluation & Staging, Treatment Response Monitoring, MBI-Guided Biopsy & Other Applications); By End User (Hospitals & Specialty Cancer Centers, Diagnostic Imaging Centers, Academic & Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

How Is the Molecular Breast Imaging Market Expanding Through Dense-Breast Screening and CZT-B? – (Updated On: 7th-Oct-2026)

The Global Molecular Breast Imaging Market was valued at USD 515 million in 2025 and is projected to reach USD 820 million by 2032, e... Read More

Published Date: JAN-2026 | No Of Pages:193 | $ 4485

Adrenocorticotropic Hormone Market By Product Type (Natural ACTH, Synthetic ACTH Analogs); By Indication (Infantile Spasms, Multiple Sclerosis, Nephrotic Syndrome, Other Rare Indications); By Route of Administration (Intramuscular, Subcutaneous, Extended-Release/Depot); By End User (Hospitals & Tertiary Care, Specialty Clinics, Home Care & Specialty Pharmacy); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Adrenocorticotropic Hormone Market will witness a steady CAGR of 5.9%, valued at $1.17 billion in 2024, and projected to reach $1.66 billion by 20... Read More

Published Date: JAN-2026 | No Of Pages:157 | $ 4485

Aromatase Deficiency Market By Therapy Type (Estrogen Replacement Therapy, Combination Hormone Therapy, Gene Therapy and Novel Endocrine Modulators); By Route of Administration (Oral, Transdermal, Injectable); By Distribution Channel (Hospital Pharmacies, Specialty Clinics, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Aromatase Deficiency Market will witness a steady CAGR of 6.8%, valued at USD 423 million in 2024, and is expected to reach USD 628 million by 2030, accor... Read More

Published Date: JAN-2026 | No Of Pages:167 | $ 4485

Lincomycin Market By Product Form (Injection, Capsule, Granule/Powder); By Application (Human Therapeutics, Veterinary Medicine, Industrial Use); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Lincomycin Market valued at USD 1.2 billion in 2024 and projected to reach USD 1.7 billion by 2030 at 5.6% CAGR, driven by antibiotic demandRead More

Published Date: JAN-2026 | No Of Pages:183 | $ 4485

Appetite Stimulant Market By Pharmacological Class (Progestational Agents, Cannabinoid-Based Therapies, CNS-Active Agents, Corticosteroids); By Drug Type (Megestrol Acetate, Corticosteroids, Cannabinoids, Cyproheptadine, Mirtazapine, Other Appetite Stimulants, Emerging Targeted Therapies); By Indication (Cancer-Associated Anorexia and Cachexia, HIV/AIDS-Associated Wasting, Chronic Disease-Associated Appetite Loss, Geriatric Appetite Decline, Other Applications); By Route of Administration (Oral, Injectable, Other Routes); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By End User (Hospitals and Clinics, Specialty Care Centers, Homecare Settings); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

What Is the Current Appetite Stimulant Market Size and How Is the Treatment Landscape Evolving? – (Updated On: 06-Sep-2026)

The Global Appetite Stimulant Market was valued at USD 1.46 billion in 2025 and is projected to reach USD 2.23 billion by 2032, expan... Read More

Published Date: JAN-2026 | No Of Pages:172 | $ 4485

Medication-Assisted Treatment Market By Drug Type (Buprenorphine, Methadone, Naltrexone, Others); By Route of Administration (Oral, Sublingual, Injectable, Implantable); By Application (Opioid Use Disorder, Alcohol Use Disorder, Other Substance Use Disorders); By End User (Specialty Addiction Treatment Centers, Hospitals & Clinics, Telehealth Platforms, Correctional Facilities, Retail Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Medication-Assisted Treatment Market is poised for substantial expansion, projected to grow at a CAGR of 6.9% between 2024 and 2030. The market is currently valued at USD 4.7 billi... Read More

Published Date: JAN-2026 | No Of Pages:189 | $ 4485

Surgical Incision Closure Devices Market By Product Type (Sutures, Staplers, Adhesives & Sealants, Closure Strips & Clips); By Application (General Surgery, Orthopedic Surgery, Cardiovascular & Thoracic Surgery, Gynecology & Obstetrics, Cosmetic & Reconstructive Surgery); By End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Surgical Incision Closure Devices Market is projected to grow at a steady CAGR of 6.5%, valued at approximately USD 8.7 billion in 2024, and forecasted to reach US... Read More

Published Date: JAN-2026 | No Of Pages:168 | $ 4485

Extremity Tissue Expanders Market By Product Type (Rectangular Expanders, Crescent Expanders, Anatomically Shaped Expanders, Custom/3D Expanders); By Application (Trauma Reconstruction, Oncology Resections, Congenital Deformities, Burn Contracture Releases, Orthopedic Grafting Prep); By End User (Hospitals, Reconstructive Surgery Clinics, Pediatric Orthopedic Centers, Military & Burn Units, Ambulatory Surgical Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Extremity Tissue Expanders Market valued at USD 512 million in 2024 and projected to reach USD 730 million by 2030 at 6.1% CAGR, driven by reconst... Read More

Published Date: JAN-2026 | No Of Pages:194 | $ 4485

Neurology Ultrasonic Aspirators Market by Product Type (Handheld, Fixed), by Application (Tumor Resection, Epilepsy Surgery, Neurodegenerative Diseases, Spinal Procedures), by End User (Hospitals, Specialized Surgical Centers, Ambulatory Surgical Centers, Research and Academic Institutions), by Region, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Neurology Ultrasonic Aspirators Market is poised for substantial growth, expected to witness a compound annual growth rate (CAGR) of 6.4%, valued at approximately USD 1.8 billion in 2024<... Read More

Published Date: JAN-2026 | No Of Pages:151 | $ 4485

Severe Hypertriglyceridemia Treatment Market By Drug Class (Fibrates, Omega-3 Derivatives, Statins, Niacin, Emerging Biologics); By Route of Administration (Oral, Injectable); By End User (Hospitals & Specialty Clinics, Retail & Hospital Pharmacies, Research & Academic Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Severe Hypertriglyceridemia Treatment Market is projected to grow at a CAGR of 8.1%, valued at approximately USD 2.6 billion in 2024, and... Read More

Published Date: JAN-2026 | No Of Pages:173 | $ 4485

Viral Hemorrhagic Fever (VHF) Market By Pathogen Type (Filoviruses, Arenaviruses, Bunyaviruses, Flaviviruses); By Intervention (Vaccines, Antivirals & Therapeutics, Diagnostics, Surveillance Systems); By End User (Public Health Agencies, Hospitals & Clinics, Military, NGOs, Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Viral Hemorrhagic Fever (VHF) Market will witness a robust CAGR of 9.8%, valued at USD 1.8 billion in 2024, and expected to appreciate and reach USD 3.2 billi... Read More

Published Date: JAN-2026 | No Of Pages:150 | $ 4485

Cardioselective Beta Blockers Market By Product Type (Bisoprolol, Metoprolol, Atenolol, Nebivolol, Acebutolol, Celiprolol, Landiolol, Other Cardioselective Beta Blockers); By Dosage Form (Tablets, Extended-Release Capsules, Injectable/Intravenous Formulations); By Application (Heart Failure, Hypertension, Cardiac Arrhythmias, Angina Pectoris, Post-Myocardial Infarction Management, Perioperative and Acute Heart-Rate Control, Other Cardiovascular Applications); By End User (Hospitals, Cardiology Clinics, Ambulatory Surgical Centers, Retail and Community Pharmacies, Online and Mail-Order Pharmacies); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Cardioselective Beta Blockers Market: Stable Prescription Demand Meets Generic Price Compression and Hospital-Led Value Creation Recurring Cardiovascular Care Sustains a Mature Pharmaceutical Market

The Global Cardioselective Beta Blockers Market was valued ... Read More

Published Date: JUL-2026 | No Of Pages:165 | $ 4485

Thrombocythemia Market By Treatment Type (Cytoreductive Therapy, Targeted Therapies, Antiplatelet Agents, Stem Cell Transplant and Experimental Therapies); By Diagnostic Method (Complete Blood Count, Bone Marrow Biopsy, Molecular Testing); By End User (Hospitals & Specialty Hematology Centers, Diagnostic Laboratories, Retail & Online Pharmacies); By Region, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Thrombocythemia Market is projected to expand steadily, growing at an estimated CAGR of 6.1%, valued at USD 1.9 billion in 2024 and expec... Read More

Published Date: JAN-2026 | No Of Pages:197 | $ 4485

Specimen Containers Market By Product Type (Urine Containers, Stool Containers, Blood Specimen Containers, Tissue Sample Containers, Sputum & Microbiology Containers, Specialty Containers); By Material Type (Polypropylene, Polyethylene, Medical-Grade Plastics, Biodegradable Plastics); By Application (Clinical Diagnostics, Research & Academic Use, Home Collection & D2C Testing); By End User (Hospitals & Clinics, Diagnostic Laboratories, Academic & Research Institutes, Home Healthcare & Telemedicine Providers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Specimen Containers Market valued at USD 3.1 billion in 2024 and projected to reach USD 4.47 billion by 2030 at 6.3% CAGR, driven by medical devic... Read More

Published Date: JAN-2026 | No Of Pages:160 | $ 4485

Magnetic Resonance Elastography Market By Application (Liver, Neurology, Breast, Musculoskeletal, Others); By Component Type (Hardware, Software); By End User (Tertiary Hospitals, Imaging Centers, Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Magnetic Resonance Elastography (MRE) Market is projected to expand at a compelling CAGR of 8.1%, reaching USD 453.7 million by 2... Read More

Published Date: JAN-2026 | No Of Pages:167 | $ 4485

Amnestic Disorders Therapeutics Market By Drug Class (Cholinesterase Inhibitors, NMDA Receptor Antagonists, GABA Modulators, Neuroregenerative Agents); By Route of Administration (Oral, Injectable, Transdermal); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Amnestic Disorders Therapeutics Market is projected to grow at a steady pace, with an estimated value of $4.8 billion in 2024, expected to reach around $7.2 billion by 2030Read More

Published Date: JAN-2026 | No Of Pages:150 | $ 4485

Myelofibrosis Market By Therapy Class (JAK Inhibitors, Antifibrotic Agents, Immunotherapies, Telomerase Inhibitors); By Route of Administration (Oral, Injectable); By Distribution Channel (Hospital Pharmacies, Specialty Pharmacies, Retail & Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Myelofibrosis Market valued at USD 1.8 billion in 2024 and projected to reach USD 3.4 billion by 2030 at 10.5% CAGR, driven by rare disease treatm... Read More

Published Date: JAN-2026 | No Of Pages:168 | $ 4485

Cardiovascular Drugs Market By Therapeutic Class (Antihypertensives, Statins, Anticoagulants, Antiplatelets, Biologics & RNA-based Drugs); By Application (Hypertension, Hyperlipidemia, Coronary Artery Disease, Heart Failure, Arrhythmias, Thrombosis); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online/Mail-Order Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cardiovascular Drugs Market valued at USD 155.2 billion in 2024 and projected to reach USD 214.3 billion by 2030 at 5.6% CAGR, driven by cardiovas... Read More

Published Date: JAN-2026 | No Of Pages:158 | $ 4485

Intra-Abdominal Infection Market By Infection Type (Complicated, Uncomplicated); By Drug Class (Antibiotics, Antifungals, Supportive Therapies); By Pathogen (Aerobic, Anaerobic, Mixed); By End User (Hospitals, Ambulatory Surgical Centers, Outpatient Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Intra-Abdominal Infection Market valued at USD 8.6 billion in 2024 and projected to reach USD 12.7 billion by 2030 at 6.7% CAGR, driven by antibio... Read More

Published Date: JAN-2026 | No Of Pages:150 | $ 4485

Sedative-Hypnotic Drugs Market by Drug Type (Benzodiazepines, Non-Benzodiazepine Sleep Aids, Barbiturates, Melatonin Receptor Agonists, Other Sedative-Hypnotics); By Application (Sleep Disorders, Anxiety Disorders, Severe Mental Health Disorders); By End User (Hospitals, Outpatient Clinics, Pharmacies, Research Institutions); By Region, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Sedative-Hypnotic Drugs Market is projected to reach USD 5.8 billion in 2024 and is expected to grow at a CAGR of 5.8% from 2024 to 2030, reaching an esti... Read More

Published Date: JAN-2026 | No Of Pages:179 | $ 4485

Endocrine Disorders Market By Application / Indication (Diabetes Mellitus, Thyroid Disorders, Obesity & Metabolic Disorders, Reproductive and Fertility Disorders, Adrenal & Pituitary Disorders); By Product / Therapy Type (Insulin Therapies, Oral Antidiabetic Drugs & Non-Insulin Injectables, Hormone Replacement Therapies); By Diagnostic Test Type (Thyroid Stimulating Hormone [TSH] Tests, Reproductive/Sex Hormone Tests, Metabolic and Endocrine Assays); By Technology (Immunoassay Technology, Mass Spectrometry, Clinical Chemistry Platforms); By End User (Hospitals, Commercial and Independent Diagnostic Laboratories, Specialty Clinics and Retail Pharmacies); By Geography (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa), Segment Revenue Estimation, Forecast, 2026–2032

Diabetes and Metabolic Care Expand the Endocrine Revenue Base – (Updated On: 29th-Sep-2026)

The Global Endocrine Disorders Market was valued at USD 13.74 billion in 2025 and is projected to reach USD 22.94 billion by 2032, expanding at a CAGR of 7.6% during... Read More

Published Date: AUG-2026 | No Of Pages:173 | $ 4485

Orexin Receptor Antagonist Market By Drug Type (Dual Orexin Receptor Antagonists, Selective Orexin Receptor Antagonists); By Application (Insomnia, Narcolepsy, Anxiety & Depression-Related Sleep Disorders, PTSD); By Route of Administration (Oral, Sublingual Film, Liquid Suspension, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Orexin Receptor Antagonist Market is on a sharp upward trajectory. It’s estimated to be worth $2.6 billion in 2024 and is projected to reach $ 6.52 ... Read More

Published Date: JAN-2026 | No Of Pages:154 | $ 4485

Coronary Guidewires Market By Product Type (Conventional Guidewires, Specialty Guidewires); By Coating (Hydrophilic, Hydrophobic, Polymer-Coated); By Application (Angioplasty, Stent Placement, Chronic Total Occlusion); By End User (Hospitals, Cardiac Specialty Centers, Ambulatory Surgical Centers, Community Hospitals); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Coronary Guidewires Market valued at USD 1.25 billion in 2024 and projected to reach USD 1.85 billion by 2030 at 6.5% CAGR, driven by cardiovascul... Read More

Published Date: JAN-2026 | No Of Pages:171 | $ 4485

Laryngeal Cancer Therapeutics Market By Therapy Type (Chemotherapy, Targeted Therapy, Immunotherapy, Radiation Therapy, Surgery); By Route of Administration (Oral, Intravenous, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Laryngeal Cancer Therapeutics Market projected to reach USD 4.1 billion by 2030 from USD 2.6 billion in 2024, registering 6.8% CAGR, supported by ... Read More

Published Date: JAN-2026 | No Of Pages:187 | $ 4485

Fascioliasis Market By Product Type (Antiparasitic Drugs, Diagnostics, Supportive & Biliary Complication Management, Emerging Second-Line Therapies); By Drug Type (Triclabendazole, Nitazoxanide and Other Off-Label Antiparasitic Drugs, Pipeline and Investigational Therapies); By Diagnostic Modality (Serology, Stool Microscopy, Molecular and Antigen-Based Tests, Bloodwork and Liver Function Testing, Ultrasound, CT and MRI Imaging); By End User (Public Health Agencies and International Treatment Programs, Hospitals and Rural Health Centers, Diagnostic Laboratories, Specialty Gastroenterology and Infectious Disease Centers); By Region (Latin America, Asia-Pacific, Middle East and Africa, Europe and North America); Segment Revenue Estimation, Forecast, 2026–2032

Fascioliasis Market: Diagnostic Gaps and Single-Drug Dependence Shape Revenue Growth

The Global Fascioliasis Market is valued at approximately USD 420 million in 2025 and is projected to reach USD 623 million by 2032, expanding at a CAGR of 5.79%, according to Strateg... Read More

Published Date: JUL-2026 | No Of Pages:156 | $ 4485

Ovulation Inducing Drugs Market By Drug Type (Clomiphene Citrate, Aromatase Inhibitors, Gonadotropins, Dopamine Agonists, Others); By Route of Administration (Oral, Injectable); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

What Is the Current Ovulation Inducing Drugs Market Size and How Is the Treatment Landscape Evolving? – (Updated On: 8th-Sep-2026)

The Global Ovulation Inducing Drugs Market was valued at USD 3.34 billion in 2025 and is projected to reach USD 5.33 billion b... Read More

Published Date: JAN-2026 | No Of Pages:182 | $ 4485

Ultramicrotome Market By Product Type (Glass Knife Ultramicrotomes, Diamond Knife Ultramicrotomes, Cryo-Ultramicrotomes); By Application (Biological Research, Materials Science, Pharmaceutical R&D); By End User (Academic & Research Institutes, Pharmaceutical & Biotech Companies, CROs, Industrial Labs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Ultramicrotome Market growing from USD 52.6 million in 2024 to USD 74.9 million by 2030, reflecting 6.0% CAGR growth, driven by electron microscop... Read More

Published Date: JAN-2026 | No Of Pages:151 | $ 4485

Lancets Market By Product Type (Standard Lancets, Safety Lancets); By Application (Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Others); By End User (Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings, Others); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Lancets Market projected to reach USD 5.09 billion by 2030 from USD 3.1 billion in 2024, registering 8.6% CAGR, supported by blood samplingRead More

Published Date: JAN-2026 | No Of Pages:183 | $ 4485

Immune Thrombocytopenia (ITP) Market By Drug Class (Thrombopoietin Receptor Agonists, FcRn Inhibitors, Monoclonal Antibodies, Syk Inhibitors, Others); By Route of Administration (Oral, Parenteral, Subcutaneous); By End User (Hospitals, Specialty Hematology Clinics, Retail & Specialty Pharmacies, Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Immune Thrombocytopenia (ITP) Market is projected to grow at a CAGR of 6.8%, valued at approximately USD 2.5 billion in 2024 and expected to reach nearly USD 3.9 b... Read More

Published Date: JAN-2026 | No Of Pages:196 | $ 4485

Electric Impedance Tomography Market By Product Type (Standalone Systems, Integrated Ventilator-Based Modules, Wearable & Portable Devices); By Application (Pulmonary Monitoring, Neonatal & Pediatric Care, Neurological Applications, Oncology & Other Uses); By End User (Hospitals & ICUs, Specialty & Pediatric Clinics, Academic & Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Electric Impedance Tomography Market valued at USD 82 million in 2024 and projected to reach USD 137 million by 2030 at 7.8% CAGR, driven by medic... Read More

Published Date: JAN-2026 | No Of Pages:194 | $ 4485

Visceral Pain Treatment Market By Treatment Type (Gastrointestinal Prescription Therapies, Hormonal and GnRH-Based Therapies, Analgesics and Supportive Drug Therapies, Neuromodulation Devices, Bladder Pain Therapies, Organ-Directed Procedures and Other Treatments); By Indication (Irritable Bowel Syndrome, Endometriosis-Associated Pain, Interstitial Cystitis/Bladder Pain Syndrome, Functional Abdominal Pain, Chronic Pancreatitis, Cancer-Related Visceral Pain, Other Visceral Pain Conditions); By End User (Hospitals, Gastroenterology Centers, Gynecology and Women’s Health Clinics, Urology Clinics, Pain Management Clinics, Pediatric Specialty Clinics, Others); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Visceral Pain Treatment Market Benefits from IBS Drug Demand, Endometriosis Access Expansion, and Organ-Specific Non-Opioid Development

The Global Visceral Pain Treatment Market was valued at USD 16.4 billion in 2025 and is projected to reach USD 24.35 billion by 2032... Read More

Published Date: JUL-2026 | No Of Pages:180 | $ 4485

Virology Testing Market By Testing Technology (Molecular Diagnostics, Immunoassays, Rapid Antigen Testing, Viral Sequencing, Viral Culture); By Virus Type (Respiratory Viruses, Hepatitis Viruses, HIV, Herpesviruses, Gastrointestinal Viruses, Vector-Borne Viruses); By Product Type (Diagnostic Kits, Testing Reagents, Laboratory Instruments, Testing Services); By Sample Type (Respiratory Swabs, Blood, Serum, Plasma, Saliva, Stool, Tissue Samples); By Application (Infection Diagnosis, Viral Load Monitoring, Blood Screening, Disease Surveillance, Treatment Monitoring); By End User (Hospitals, Diagnostic Laboratories, Research Institutes, Public Health Laboratories, Blood Banks); By Geography (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa), Segment Revenue Estimation, Forecast, 2026–2032

Virology Testing Market: How Are Molecular Diagnostics and Viral Surveillance Shaping Growth? – (Updated On: 22nd-Oct-2026)

The Global Virology Testing Market was valued at an estimated USD 7.91 billion in 2025 and is projected to reach USD 11.69 billion by... Read More

Published Date: JAN-2026 | No Of Pages:188 | $ 4485

Erythroid Maturation Agent Market By Drug Type (Luspatercept, Next-Gen Ligand Traps, Experimental SMAD Modulators); By Indication (Transfusion-Dependent Beta-Thalassemia, Myelodysplastic Syndromes, Others); By Route of Administration (Subcutaneous, Oral [Pipeline]); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Erythroid Maturation Agent Market projected to reach USD 1.65 billion by 2030 from USD 1.12 billion in 2024, registering 6.5% CAGR, supported by b... Read More

Published Date: JAN-2026 | No Of Pages:187 | $ 4485

Cardiac Sarcoidosis Market By Product Type (Diagnostics, Therapeutics, Devices & Supportive Care); By Diagnostic Modality (PET, Cardiac MRI, Endomyocardial Biopsy, Blood-Based & Biomarker Tests); By Treatment Approach (Corticosteroids, Immunosuppressants, Biologics & Targeted Therapies, Device-Based Interventions); By End User (Hospitals & Specialty Cardiac Centers, Diagnostic Imaging Centers, Research & Academic Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cardiac Sarcoidosis Market valued at USD 1.1 billion in 2024 and projected to reach USD 1.9 billion by 2030 at 8.5% CAGR, driven by cardiac diagno... Read More

Published Date: JAN-2026 | No Of Pages:195 | $ 4485

Critical Care Devices Market By Product Type (Ventilators, Patient Monitoring Systems, Infusion Pumps, Dialysis Equipment, Anesthesia Machines, Other Critical Care Devices); By Application (Respiratory Care, Cardiovascular Care, Neurological Care, Renal Care, Other Applications); By End User (Hospitals, Ambulatory Surgical Centers, Long-Term Care Facilities, Diagnostic Imaging Centers, Emergency Medical Services); By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa); Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Critical Care Devices Market growing at 6.5% CAGR, expanding from USD 10.2 billion in 2024 to USD 18.5 billion by 2030, fueled by intensive care u... Read More

Published Date: JAN-2026 | No Of Pages:161 | $ 4485

Temporal Arteritis Market By Drug Class (Corticosteroids, Interleukin-6 Inhibitors, Immunosuppressants, JAK Inhibitors); By Route of Administration (Oral, Parenteral); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography (North America, Europe, Asia Pacific, Latin America, Middle East & Africa), Segment Revenue Estimation, Forecast, 2026–2032

How Is the Temporal Arteritis Market Evolving, and What Is Driving Its Growth? – (Updated On: 07-Sep-2026)

The Global Temporal Arteritis, or Giant Cell... Read More

Published Date: JAN-2026 | No Of Pages:171 | $ 4485

Hemorrhagic Stroke Treatment Market By Treatment Type (Drug Therapy, Surgical Intervention, Endovascular Procedures, Monitoring & Supportive Devices); By Cause/Condition (Intracerebral Hemorrhage, Subarachnoid Hemorrhage, Other Rare Hemorrhages); By End User (Tertiary Hospitals, General Hospitals, Ambulatory Surgical Centers); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Hemorrhagic Stroke Treatment Market Scales Through ICU Severity, Aneurysm Repair, and Selective Device Evidence

The Global Hemorrhagic Stroke Treatment Market was valued at USD 4.12 billion in 2025 and is projected to reach USD 6.27 billion by 2032, growing at a CAGR ... Read More

Published Date: JUL-2026 | No Of Pages:175 | $ 4485

Osteomyelitis Market By Type (Chronic Osteomyelitis, Acute Osteomyelitis, Diabetic Foot Osteomyelitis, Vertebral Osteomyelitis); By Treatment (Antibiotics, Surgical Treatment, Local Antibiotic Delivery, Bone Reconstruction/Grafting, Adjunctive Therapy); By Pathogen (Staphylococcus aureus [S. aureus], Methicillin-Resistant Staphylococcus aureus [MRSA], Gram-Negative Bacteria, Polymicrobial Infections, Other Pathogens); By Anatomical Site (Long Bones, Foot & Ankle, Spine, Pelvis, Other Anatomical Sites); By Patient Type (Adults, Pediatric Patients); By End User (Hospitals, Orthopedic & Specialty Clinics, Ambulatory Surgical Centers, Other End Users); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

How Are Rising Diabetic Foot Complications and Prolonged Infection Treatment Reshaping the Osteomyelitis Market? – (Updated On: 7th-Oct-2026)

The Global Osteomyelitis Market was valued at USD 1.34 billion in 2025 and is projected to reach USD 2.24 billion b... Read More

Published Date: JAN-2026 | No Of Pages:170 | $ 4485

Swab and Viral Transport Medium Market By Product Type (Swabs [Flocked, Foam, Cotton], Viral Transport Media [Standard VTM, Molecular VTM, Dry Transport]); By Application (Infectious Diseases, STI Testing, Surveillance Programs); By End User (Hospitals & Diagnostic Labs, Point-of-Care Settings, Public Health Agencies, CROs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Swab And Viral Transport Medium Market valued at USD 1.65 billion in 2024 and projected to reach USD 2.34 billion by 2030 at 5.9% CAGR, driven by ... Read More

Published Date: JAN-2026 | No Of Pages:187 | $ 4485

Topical Antibiotics Market By Product Type (Mupirocin, Fusidic Acid, Neomycin & Bacitracin, Clindamycin & Erythromycin, Others); By Formulation (Ointments & Creams, Gels & Lotions, Eye/Ear Drops, Powders & Sprays); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Topical Antibiotics Market projected to reach USD 6.5 billion by 2030 from USD 4.6 billion in 2024, registering 5.9% CAGR, supported by dermatolog... Read More

Published Date: JAN-2026 | No Of Pages:163 | $ 4485

Erythropoietin Stimulating Agents (ESA) Market By Drug Type (Biologics, Biosimilars); By Application (Chronic Kidney Disease, Oncology-Associated Anemia, HIV & Other Indications); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Erythropoietin Stimulating Agents (ESA) Market valued at USD 9.8 billion in 2024 and reaching USD 13.7 billion by 2030 at 5.7% CAGR, driven by ane... Read More

Published Date: JAN-2026 | No Of Pages:183 | $ 4485

Dilated Cardiomyopathy Market By Therapy (Pharmacological Treatments, Novel & Targeted Therapies); By Device (ICDs & CRT-Ds, LVADs, Wearable Monitoring Devices); By Diagnostic Approach (Echocardiography, Cardiac MRI, Genetic Testing); By End User (Hospitals & Cardiac Centers, Specialty Clinics, Diagnostic Laboratories); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Dilated Cardiomyopathy Market valued at USD 2.9 billion in 2024 and reaching USD 4.6 billion by 2030 at 7.9% CAGR, driven by cardiovascular diseas... Read More

Published Date: JAN-2026 | No Of Pages:198 | $ 4485

Thoracoscopy Market By Product Type (Rigid Thoracoscopes, Flexible Thoracoscopes, Video-Assisted Systems, Robotic-Assisted Systems); By Application (Diagnostic Thoracoscopy, Therapeutic Thoracoscopy); By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Training & Academic Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Thoracoscopy Market will witness a steady CAGR of 6.8%, valued at USD 1.35 billion in 2024, and expected to reach USD 2.01 billion by 2030, confirms Read More

Published Date: JAN-2026 | No Of Pages:184 | $ 4485

IgG4-Related Disease Market By Treatment Type (Corticosteroids, Immunosuppressive Drugs, Biologics, Small Molecules); By Diagnostic Method (Serological Testing, Imaging, Biopsy, Digital Pathology, Biomarker Panels); By End User (Tertiary Care Hospitals, Specialty Clinics, Reference Laboratories, Academic & Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global IgG4-Related Disease Market valued at USD 2.1 billion in 2024 and projected to reach USD 3.5 billion by 2030 at 7.5% CAGR, driven by rare disease ... Read More

Published Date: JAN-2026 | No Of Pages:187 | $ 4485

Clinical Communication and Collaboration Market By Component (Solutions, Services); By Deployment Mode (On-Premise, Cloud-Based); By End User (Hospitals & Health Systems, Ambulatory Surgical Centers, Physician Groups, Long-Term Care Providers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Clinical Communication And Collaboration (CC&C) Market valued at USD 6.9 billion in 2024 and projected to reach USD 16.55 billion by 2030 at 15.7% CAGRRead More

Published Date: JAN-2026 | No Of Pages:189 | $ 4485

Budesonide Inhaler Market By Product Type (Dry Powder Inhalers, Metered Dose Inhalers, Nebulized Suspensions); By Indication (Asthma, Chronic Obstructive Pulmonary Disease, Allergic Rhinitis, Others); By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Budesonide Inhaler Market valued at USD 2.36 billion in 2024 and projected to reach USD 3.31 billion by 2030 at 5.8% CAGR, driven by asthma treatm... Read More

Published Date: JAN-2026 | No Of Pages:169 | $ 4485

Allergy Vaccine Market By Allergy Type (Pollen, Dust Mite, Animal Dander, Food Allergens, Insect Venom); By Route of Administration (Subcutaneous, Sublingual, Oral); By End User (Allergy Clinics, Hospitals, Pediatric Clinics, Retail Pharmacies, Telemedicine Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Allergy Vaccine Market valued at USD 2.6 billion in 2024 and projected to reach USD 4.2 billion by 2030 at 8.4% CAGR, driven by allergy immunother... Read More

Published Date: JAN-2026 | No Of Pages:154 | $ 4485

Dural Repair Market By Product Type (Dural Substitutes, Sealants and Adhesives, Sutures and Hemostatic Agents); By Application (Spinal Surgery, Cranial Surgery, Trauma and Emergency Procedures, Congenital Abnormalities); By End User (Hospitals, Ambulatory Surgical Centers, Specialty Neurosurgical Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Dural Repair Market valued at USD 1.12 billion in 2024 and projected to reach USD 1.67 billion by 2030 at 6.8% CAGR, driven by neurosurgery device... Read More

Published Date: JAN-2026 | No Of Pages:184 | $ 4485

PPG Biosensors Market By Product Type (Discrete Modules, Integrated SoCs, Flexible Printed Sensors); By Application (Cardiac Monitoring, SpO₂ Measurement, Respiratory Rate, Stress & Wellness Analytics); By End User (Consumer Electronics, Healthcare OEMs, Hospitals & Clinics, RPM Providers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global PPG Biosensors Market will witness a steady CAGR of 9.1%, valued at USD 1.2 billion in 2024 and projected to surpass Read More

Published Date: JAN-2026 | No Of Pages:188 | $ 4485

Inhaled Nitric Oxide Market By Application (Neonatal Respiratory Failure, ARDS, Post-Operative Cardiac Surgery, Organ Transplantation, COPD & Interstitial Lung Diseases); By Delivery System (Standalone Hospital Systems, Transport/Portable Units, Integrated Ventilator Modules); By End User (Neonatal & Pediatric ICUs, Adult ICUs, Cardiothoracic Surgery Centers, Emergency Medical & Transport Teams); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Inhaled Nitric Oxide Market valued at USD 980 million in 2024 and projected to reach USD 1.41 billion by 2030 at 6.3% CAGR, driven by neonatal car... Read More

Published Date: JAN-2026 | No Of Pages:175 | $ 4485

Childhood Absence Epilepsy Treatment Market By Drug Class (First-Line Antiepileptic Drugs, Second-Line/Add-On Therapies); By Route of Administration (Oral Solid, Oral Liquid, Others); By End User (Hospitals & Specialty Clinics, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Childhood Absence Epilepsy (CAE) Treatment Market is projected to reach $2.34 billion by 2030 , growing from an estimated $1.48 billion in 2024Read More

Published Date: JAN-2026 | No Of Pages:200 | $ 4485

Cardiac Ablation Market By Technology Type (Radiofrequency Ablation, Cryoablation, Pulsed Field Ablation, Others); By Application (Atrial Fibrillation, Atrial Flutter, Supraventricular Tachycardia, Ventricular Tachycardia, Others); By End User (Hospitals, Electrophysiology Labs, Ambulatory Surgical Centers, Specialty Cardiology Clinics); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

What Is the Cardiac Ablation Market Size and What Is Shaping Its Clinical Landscape?  – (Updated On: 06-Sep-2026)

The Global Cardiac Ablation Market was valued at USD 8.22 billion in 2025 and is projected to reach USD 18.95 billion by 2032, expanding a... Read More

Published Date: JAN-2026 | No Of Pages:186 | $ 4485

Supraventricular Tachycardia Treatment Market By Treatment Type (Acute Self-Administered Prescription Therapies, Hospital-Administered Acute Drugs, Chronic Oral Pharmacotherapy, Catheter Ablation, Electrical Cardioversion); By Application (Paroxysmal Supraventricular Tachycardia, Atrioventricular Nodal Re-entrant Tachycardia, Atrioventricular Re-entrant Tachycardia, Wolff-Parkinson-White Syndrome-Associated SVT, Focal Atrial Tachycardia, Recurrent Symptomatic SVT, Pediatric Supraventricular Tachycardia); By End User (Hospitals and Emergency Departments, Cardiology Clinics, Electrophysiology Centres, Ambulatory Surgical Centres, Retail Pharmacies, Specialty Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Supraventricular Tachycardia Treatment Market: Outpatient Episode Control Redirects Revenue from Emergency Care to Prescription and Ablation Channels

The Global Supraventricular Tachycardia Treatment Market was valued at USD 4.99 billion in 2025 and is projected to re... Read More

Published Date: JUL-2026 | No Of Pages:177 | $ 4485

Cardiac Computed Tomography Market By Technology Type (64-Slice CT, 128–256 Slice CT, Dual-Source and Ultra-High-Resolution CT); By Application (Coronary Artery Disease Diagnosis, Calcium Scoring, Structural Heart Planning, Congenital Heart Imaging, Pre-operative Risk Assessment); By End User (Tertiary Hospitals, General Hospitals, Outpatient Imaging Centers, Specialty Cardiology Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cardiac Computed Tomography Market valued at USD 1.9 billion in 2024 and reaching USD 3.2 billion by 2030 at 7.8% CAGR, driven by cardiac imaging<... Read More

Published Date: JAN-2026 | No Of Pages:181 | $ 4485

Nexletol Market By Drug Type (Monotherapy, Combination Therapy); By Therapeutic Application (ASCVD, HeFH); By End User (Cardiology Clinics, Hospitals, Primary Care, Pharmacies); By Distribution Channel (Specialty Pharmacies, Retail Pharmacies, Hospital Pharmacies, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Nexletol Market valued at USD 1.2 billion in 2024 and projected to reach USD 2.7 billion by 2030 at 14% CAGR, driven by cholesterol managementRead More

Published Date: JAN-2026 | No Of Pages:160 | $ 4485

Tamoxifen Market By Product Type (Oral Tablet, Liquid Formulation, Compounded Formulation); By Application (Adjuvant Therapy, Metastatic Breast Cancer, Risk Reduction/Prevention); By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online/Specialty Pharmacy); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Tamoxifen Market valued at USD 700 million in 2024 and projected to reach USD 995 million by 2030 at 6.1% CAGR, driven by breast cancer treatment<... Read More

Published Date: JAN-2026 | No Of Pages:160 | $ 4485

Etanercept Market By Product Type (Originator Etanercept, Etanercept Biosimilars); By Indication (Rheumatoid Arthritis, Plaque Psoriasis, Psoriatic Arthritis, Ankylosing Spondylitis, Non-Radiographic Axial Spondyloarthritis, Juvenile Idiopathic Arthritis); By Dosage Form and Delivery System (Pre-Filled Syringes, Autoinjectors and Pens, Vials and Other Presentations); By Distribution Channel (Hospital Pharmacies, Specialty Pharmacies, Retail Pharmacies, Government and Public Procurement Channels); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Etanercept Market: Medicare Price Cuts and Biosimilar Switching Separate Treatment Volume from Revenue Growth

The Global Etanercept Market was valued at USD 21.0 billion in 2025 and is projected to reach USD 28.6 billion by 2032, growing at a CAGR of 4.5% during the f... Read More

Published Date: JUL-2026 | No Of Pages:150 | $ 4485

Viral Gastroenteritis Market By Product Type (Diagnostics, Vaccines, Therapeutics, Oral Rehydration); By Virus Type (Rotavirus, Norovirus, Adenovirus, Astrovirus, Sapovirus); By End User (Hospitals, Clinics, Diagnostic Labs, Home Users); By Geography, Segment Revenue Estimation, Forecast, 2025–2030

Introduction And Strategic Context

The Global Viral Gastroenteritis Market valued at USD 6.1 billion in 2024 and projected to reach USD 8.9 billion by 2030 at 6.5% CAGR, driven by infectious d... Read More

Published Date: JAN-2026 | No Of Pages:155 | $ 4485

Vesicoureteral Reflux Market By Type (Primary VUR, Secondary VUR); By Grade (Grade I, Grade II, Grade III, Grade IV, Grade V); By Treatment (Antibiotic Prophylaxis, Endoscopic Injection, Open Surgery, Minimally Invasive Surgery); By End User (Pediatric Hospitals, General Hospitals, Urology Clinics, Ambulatory Surgical Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Vesicoureteral Reflux Market is projected to grow at a CAGR of 7.9%, reaching an estimated USD 2.1 billion by 2030, up from USD 1.3 billion in 2024, accor... Read More

Published Date: JAN-2026 | No Of Pages:169 | $ 4485

Therapeutic Proteins and Oral Vaccines Market By Product Type (Monoclonal Antibodies, Recombinant Hormones & Growth Factors, Enzyme Replacement Therapies, Interferons, Oral Vaccines); By Route of Administration (Oral, Intravenous, Subcutaneous, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Therapeutic Proteins and Oral Vaccines Market valued at USD 165.7 billion in 2024 and projected to reach USD 280.6 billion by 2030 at 7.9% CAGR, driven by... Read More

Published Date: JAN-2026 | No Of Pages:181 | $ 4485

Sleep Related Hypoventilation Market By Device Type (Non-Invasive Ventilators, Invasive Ventilators, Monitoring Systems); By Application (Obesity Hypoventilation Syndrome, COPD-Related Hypoventilation, Neuromuscular Disease-Related Hypoventilation, Other Secondary Causes); By End User (Hospitals & Sleep Centers, Home Healthcare Providers, Ambulatory Surgical Centers, Long-Term Care Facilities); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Sleep Related Hypoventilation Market will witness a robust CAGR of 6.5%, valued at USD 1.2 billion in 2024, expected to appreciate and reach USD 1... Read More

Published Date: JAN-2026 | No Of Pages:186 | $ 4485

Severe Combined Immunodeficiency Market By Treatment Type (Gene Therapy, Enzyme Replacement Therapy, Hematopoietic Stem Cell Transplantation); By Patient Age Group (Neonates and Infants, Pediatric 1–12 Years, Adolescents and Adults); By End User (Hospitals, Specialty Clinics, Diagnostic Laboratories); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Severe Combined Immunodeficiency Market will witness a robust CAGR of 9.1%, valued at USD 1.2 billion in 2024, expected to reach USD 2.0 billion b... Read More

Published Date: JAN-2026 | No Of Pages:167 | $ 4485

Pharmaceutical Solvents Market By Type (Polar Solvents, Non-Polar Solvents, Co-Solvents); By Application (API Synthesis, Formulation & Excipients, Analytical Testing, Specialty Applications); By End User (Pharmaceutical Manufacturers, Biopharmaceutical Companies, CROs/CMOs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Pharmaceutical Solvents Market will witness a robust CAGR of 6.1% , valued at USD 12.8 billion in 2024 , expected to appreciate and reach USD 18.5 billion by 2030<... Read More

Published Date: JAN-2026 | No Of Pages:178 | $ 4485

Oligodendroglioma Market By Treatment Type (Surgical Resection, Chemotherapy, Radiotherapy, Targeted Therapy); By Tumor Grade (Grade II, Grade III); By End User (Tertiary Hospitals, Cancer Specialty Centers, Private Hospitals, Community Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Oligodendroglioma Market is projected to grow at a steady CAGR of 8.0% , moving from an estimated USD 421.6 million in 2024 to around Read More

Published Date: JAN-2026 | No Of Pages:197 | $ 4485

Mammography Workstation Market By Modality (2D Mammography, 3D Digital Breast Tomosynthesis, Multimodality); By Application (Screening, Diagnostic); By End User (Hospitals, Diagnostic Imaging Centers, Breast Clinics, Mobile Screening Units); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Mammography Workstation Market valued at USD 856 million in 2024 and projected to reach USD 1.28 billion by 2030 at 6.8% CAGR, driven by breast im... Read More

Published Date: JAN-2026 | No Of Pages:196 | $ 4485

Lymphadenopathy Market By Type (Localized Lymphadenopathy, Generalized Lymphadenopathy); By Diagnosis Modality (Imaging, Fine-Needle Aspiration/Core Needle Biopsy, Excisional Biopsy & Histopathology, Blood & Laboratory Tests, Molecular & Microbiology Testing); By Cause (Infectious Lymphadenopathy, Neoplastic Lymphadenopathy, Autoimmune Lymphadenopathy, Drug-Induced & Miscellaneous Lymphadenopathy); By End User (Tertiary Hospitals, General Hospitals, Specialty Clinics, Diagnostic Centers & Pathology Laboratories); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Lymphadenopathy Market: Diagnostic Escalation, Tuberculosis Burden, and Cancer Staging Turn a Common Clinical Sign into a High-Value Care Pathway

The Global Lymphadenopathy Market was valued at USD 2.25 billion in 2025 and is projected to reach USD 3.21 billion by 203... Read More

Published Date: JUL-2026 | No Of Pages:180 | $ 4485

Intra-Aortic Balloon Pump Market By Product Type (Consoles, Catheters); By Indication (Cardiogenic Shock, Acute Myocardial Infarction, CABG, Others); By End User (Tertiary & Quaternary Hospitals, Specialty Cardiac Centers, General Hospitals, Academic & Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Intra-Aortic Balloon Pump Market valued at USD 463 million in 2024 and projected to reach USD 685 million by 2030 at 5.8% CAGR, driven by cardiac ... Read More

Published Date: JAN-2026 | No Of Pages:187 | $ 4485

Gas Exchange Pulmonary Function Testing Market By Test Type (Single-Breath DLCO, Multiple-Breath Washout, Others); By Application (COPD, Asthma, Interstitial Lung Disease, Occupational Lung Disease, Cardiac Assessment); By End User (Hospitals, Outpatient Clinics, Diagnostic Labs, Home Care, Occupational Health Providers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Gas Exchange Pulmonary Function Testing Market is on track to grow at a CAGR of 6.7% , with an estimated value of USD 1.42 billion in 2024 , projected to reach USD... Read More

Published Date: JAN-2026 | No Of Pages:183 | $ 4485

Cryptococcosis Market By Treatment Type (Amphotericin B, Flucytosine, Azole Antifungals, Emerging Therapies); By Infection Type (Cryptococcal Meningitis, Pulmonary Cryptococcosis, Cutaneous & Disseminated Forms); By End User (Hospitals & Specialty Clinics, Community Clinics, Pharmacies, NGO/Government Programs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cryptococcosis Market valued at USD 6.2 billion in 2024 and projected to reach USD 8.7 billion by 2030 at 5.8% CAGR, driven by antifungal therapy<... Read More

Published Date: JAN-2026 | No Of Pages:199 | $ 4485

Ankylosing Hyperostosis Market By Treatment Type (Pharmacological Therapy, Physical Therapy & Rehabilitation, Surgical Intervention, Lifestyle & Nutritional Management); By Diagnosis Modality (X-ray, CT, MRI); By End User (Hospitals & Specialty Clinics, Rehabilitation Centers, Imaging Centers, Home Health Providers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Ankylosing Hyperostosis Market is projected to expand steadily, valued at USD 1.2 billion in 2024 and forecasted to reach USD 1.9 billion by 2030 , growin... Read More

Published Date: JAN-2026 | No Of Pages:193 | $ 4485

Alkaloid-Based Drugs Market By Product Type (Natural Alkaloid Drugs, Semisynthetic Alkaloid Derivatives, Synthetic Alkaloid Analogues); By Application (Pain Management and Cough Suppression, Oncology, Cardiovascular Disorders, Malaria and Other Infectious Diseases, Gastrointestinal and Spasmodic Disorders, Neurological Disorders, Ophthalmology, Addiction Treatment, Endocrine Disorders, Neonatal and Critical Care, Poisoning Reversal and Emergency Care); By End User (Hospitals, Oncology Centers, Specialty Clinics, Addiction Treatment Centers, Retail Pharmacies, Hospital Pharmacies, Specialty Pharmacies, Ambulatory Care Centers, Government and Public Health Organizations); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Alkaloid-Based Drugs Market: Long-Acting Buprenorphine and Earlier-Line Oncology Shift Value Beyond Generic Prescription Scale

The Global Alkaloid Based Drugs Market was valued at USD 40.85 billion in 2025 and is projected to reach Read More

Published Date: JUL-2026 | No Of Pages:171 | $ 4485

Acquired Methemoglobinemia Market By Therapeutic Type (Methylene Blue, Ascorbic Acid, Hyperbaric Oxygen Therapy, Others); By Diagnostic Method (Co-oximetry, Point-of-Care Devices, Laboratory Testing); By End User (Hospitals, Specialty Clinics, Diagnostic Laboratories, Ambulatory Surgical Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Acquired Methemoglobinemia Market will witness a robust CAGR of 8.5%, valued at USD 1.1 billion in 2024 , expected to appreciate and reach USD 1.8... Read More

Published Date: JAN-2026 | No Of Pages:162 | $ 4485

4K Medical Imaging Market By Product Type (Surgical Displays, Endoscopes and Cameras, Microscopes & Diagnostic Monitors, Recording & Streaming Systems); By Application (Surgical Imaging, Diagnostic Imaging, Training & Education, Telemedicine); By End User (Hospitals & Surgical Centers, Diagnostic Imaging Centers, Academic & Research Institutes, Ambulatory Surgical Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global 4K Medical Imaging Market is estimated at USD 2.9 billion in 2024 , projected to reach USD 5.4 billion by 2030 , expanding at a CAGR of 10.8% during the f... Read More

Published Date: JAN-2026 | No Of Pages:167 | $ 4485

Veno-Venous Extracorporeal Life Support (VV ECLS) Devices Market By Product Type (Pumps, Oxygenators, Cannulas, Integrated ECMO Systems); By Application (Acute Respiratory Distress Syndrome, Bridge-to-Transplant, Severe Pneumonia, Trauma-Induced Respiratory Failure); By End User (Hospitals, Specialty Centers, Academic Medical Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Veno-Venous Extracorporeal Life Support (VV ECLS) Devices Market will witness a robust CAGR of 6.8%, valued at U... Read More

Published Date: JAN-2026 | No Of Pages:159 | $ 4485

Intravascular Warming Systems Market By Product Type (Surface Warming Systems, Intravascular Warming Catheters, Warming Units/Accessories); By Application (Surgery/Operating Room, Intensive Care, Emergency, Pre-hospital/Transport); By End User (Hospitals, Ambulatory Surgical Centers, EMS/Pre-hospital, Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Intravascular Warming Systems Market projected to reach USD 425 million by 2030 from USD 285 million in 2024, registering 6.8% CAGR, supported by ... Read More

Published Date: JAN-2026 | No Of Pages:191 | $ 4485

Musculoskeletal Disease Management Market By Product Type (Pharmaceuticals, Medical Devices, Diagnostics, Digital Health Platforms); By Application (Osteoarthritis, Rheumatoid Arthritis, Osteoporosis, Back Pain, Sports Injuries, Post-Op Rehab); By End User (Hospitals, Specialty Clinics, Outpatient Rehab Centers, Home Care Providers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Musculoskeletal Disease Management Market will witness a steady CAGR of 6.7%, valued at an estimated $41.2 billion in 2024, and projected to reach $61.2 billion by... Read More

Published Date: JAN-2026 | No Of Pages:171 | $ 4485

Klebsiella Infection Market By Product Type (Diagnostics, Therapeutics, Infection Prevention Technologies); By Application (Hospital-Acquired Infections, Community-Acquired Infections, Surveillance/Outbreak Response); By End User (Hospitals, Laboratories, Clinics, Long-Term Care, Public Health Agencies); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Klebsiella Infection Market: Rising Drug Resistance Shifts Hospital Spending Toward Targeted Antibiotics and Rapid Diagnostics

The Global Klebsiella Infection Market is estimated to reach USD 2.88 billion in 2025 and is projected to g... Read More

Published Date: JUL-2026 | No Of Pages:158 | $ 4485

Fecal Occult Testing Market By Test Type (Guaiac-Based FOBT, Fecal Immunochemical Test, Advanced/Hybrid Tests); By Application (Colorectal Cancer Screening, Gastrointestinal Disorder Diagnostics, Routine Preventive Care); By End User (Hospitals & Clinics, Diagnostic Laboratories, Home Testing Kits); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Fecal Occult Testing Market valued at USD 1.6 billion in 2024 and projected to reach USD 2.4 billion by 2030 at 6.8% CAGR, driven by colorectal ca... Read More

Published Date: JAN-2026 | No Of Pages:173 | $ 4485

Sphygmomanometer Market by Type (Manual Sphygmomanometers, Digital Sphygmomanometers); By End User (Hospitals, Home Healthcare, Clinics, Diagnostic Centers, Ambulatory Surgical Centers); By Region, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Sphygmomanometer Market projected to reach USD 6.2 billion by 2030 from USD 3.5 billion in 2024, registering 6.1% CAGR, supported by blood pressur... Read More

Published Date: JAN-2026 | No Of Pages:180 | $ 4485

Lipid Panel Testing Market By Product Type (Complete Lipid Panel Kits, Single Analyte Tests, Quality Control Reagents); By Testing Technology (Laboratory-Based Analyzers, Point-of-Care Devices); By End User (Hospitals & Clinical Laboratories, Physician Offices & Primary Care, Retail Clinics & Pharmacies, At-Home Testing/Telehealth); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Lipid Panel Testing Market will witness a robust CAGR of 6.3%, valued at $6.8 billion in 2024, expected to appreciate and reach $9.8 billion by 2030, acco... Read More

Published Date: JAN-2026 | No Of Pages:152 | $ 4485

Urolithiasis Management Devices Market By Device Type (Lithotripsy Devices, Ureteroscopes, Laser Lithotripters, Stone Retrieval Devices, Ancillary Tools); By Procedure (Extracorporeal Shock Wave Lithotripsy, Ureteroscopy, Percutaneous Nephrolithotomy, Others); By End User (Hospitals, Ambulatory Surgery Centers, Urology Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Urolithiasis Management Devices Market is set for notable expansion, with a projected CAGR of 6.9%, valued at an estimated $2.5 billion in 2024 and expected to reach rough... Read More

Published Date: JAN-2026 | No Of Pages:173 | $ 4485

Intermittent Pneumatic Compression Devices Market By Product Type (Portable IPC Devices, Non-portable IPC Devices); By Application (DVT Prevention, Lymphedema Management, Chronic Venous Insufficiency and Varicose-Vein-Related Applications, Sports and Rehabilitation); By End User (Hospitals & Clinics, Homecare Settings, Ambulatory Surgical Centers, Sports Rehabilitation Centers); By Geography (North America, Europe, Asia-Pacific, Latin America, Middle East and Africa), Segment Revenue Estimation, Forecast, 2026–2032

Intermittent Pneumatic Compression Devices Market Overview and Growth Analysis

The Global Intermittent Pneumatic Compression (IPC) Devices Market is growing at a CAGR of 6.8%, valued at USD 4.1 billion in 2025 and expected to reach USD 6.1 billion by 2032.

... Read More

Published Date: AUG-2026 | No Of Pages:178 | $ 4485

Mobile Stroke Unit (MSU) Market By Type (Basic MSU, Advanced MSU); By Application (Acute Ischemic Stroke Care, Hemorrhagic Stroke Care, Triage & Transport); By End-User (Hospitals and Stroke Centers, EMS Providers, Government Healthcare Programs); By Region, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Mobile Stroke Unit (MSU) Market projected to reach USD 3.5 billion by 2030 from USD 1.7 billion in 2024, registering 12% CAGR, supported by emerge... Read More

Published Date: JAN-2026 | No Of Pages:160 | $ 4485

Medical Transport Box Market By Type (Passive Transport Boxes, Active Transport Boxes); By Temperature Range (Cold, Frozen, Ultra-Cold); By Material (EPS, PU Foam, Vacuum Insulated Panels, Phase Change Materials); By End Use (Hospitals, Pharmaceutical Companies, Transplant Centers, NGOs & Public Health Agencies, Diagnostic Labs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Medical Transport Box Market valued at USD 2.3 billion in 2024 and projected to reach USD 3.4 billion by 2030 at 6.4% CAGR, driven by cold chain l... Read More

Published Date: JAN-2026 | No Of Pages:194 | $ 4485

Pneumatic Tourniquet Market By Product Type (Automated, Standard, Portable); By Application (Orthopedic, Trauma, Vascular, Cosmetic); By End User (Hospitals, ASCs, Trauma Centers, Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Pneumatic Tourniquet Market will witness a steady growth trajectory, with a robust CAGR of 5.8%, valued at approximately USD 1.6 billion in 2024, expected... Read More

Published Date: JAN-2026 | No Of Pages:151 | $ 4485

Bariatric Surgery Devices Market By Product Type (Surgical Stapling Devices, Suturing Devices, Trocars & Access Instruments, Energy-Based Devices, Others); By Surgery Type (Sleeve Gastrectomy, Gastric Bypass, Adjustable Gastric Banding, BPD/DS, Endoscopic Bariatric Procedures); By End User (Hospitals, Specialty Bariatric Clinics, Ambulatory Surgical Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Bariatric Surgery Devices Market valued at USD 2.4 billion in 2024 and projected to reach USD 3.7 billion by 2030 at 7.5% CAGR, driven by obesity ... Read More

Published Date: JAN-2026 | No Of Pages:167 | $ 4485

Tissue Contact Probe Ablators Market By Product Type (Radiofrequency Ablators, Microwave Ablators, Laser Ablators, Ultrasound Ablators); By Application (Cancer, Cardiology, Pain Management, Dermatology, Others); By End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Tissue Contact Probe Ablators Market will witness a robust CAGR of 8.2%, valued at USD 1.3 billion in 2024, and expected to reach USD 2.1 billion by 2030,... Read More

Published Date: JAN-2026 | No Of Pages:168 | $ 4485